Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples